• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

Holmusk, a Data Science and Health Technology Company, Announces Closing of US$21.5 Million Series A Funding Round

May 18, 2020 By admin Leave a Comment

Holmusk, a leading data science and health technology company, today announced a US$21.5 million funding round. The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals.

Holmusk is building the world’s largest Real-World Evidence (RWE) platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions. This is made possible by bringing together specialty behavioral health data and Holmusk’s novel analytics platform to deliver evidence-based insight that care providers, health care payers and patients can use to make fully informed care and treatment decisions, and better integrate care for people with both behavioral and chronic health needs. These capabilities can also aid pharma companies with R&D and commercialization of new drugs.

In 2016, Holmusk acquired MindLinc, an Electronic Health Record (EHR) system focused on behavioral health, from Duke University School of Medicine. This enabled the company to leverage longitudinal data from many mental health institutions across US, stretching over 20 years.

Founded in 2015, Holmusk is headquartered in Singapore with offices in New York City, London and Shanghai. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort. The new funding round allows Holmusk to expand its US operations in New York City, and enables investment in its proprietary technology to harness and analyze real-world data to accelerate drug development and data-driven medicine.

Dr. Vijay Barathan from Optum Ventures (OV) and Charles Boorady from Health Catalyst Capital (HCC) will be joining the Board of Directors.

“Our team is encouraged by Holmusk’s evidence-based approach to improving care for people suffering from behavioral health disorders, and we look forward to working closely with the Holmusk team to support the next phase of growth” said Dr. Vijay Barathan of Optum Ventures.

Charles Boorady of Health Catalyst Capital said “by redefining the EHR from a repository of data to a clinical decision support tool with connectivity to digital therapeutics, Holmusk is uniquely positioned to improve patient care while reducing administrative burden and supporting the research and development of new care models and therapies.”

“In situations like today, the need for Real-World Evidence is more pronounced than ever,” said Nawal Roy, Holmusk’s Founder & CEO. “We are fortunate to bring on partners like Optum Ventures and Health Catalyst Capital who understand the importance and are excited to join us in our mission to drive evidence-based care.”

About Holmusk

Holmusk is on a mission to transform the lives of people with behavioral health and chronic diseases through evidence driven medicine. Headquartered in Singapore with a global footprint, it is building the world’s largest real-world evidence platform for mental health and chronic diseases. For more information, please visit www.holmusk.com.

Filed Under: PR

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

The U.S.’s blood supply had dipped to levels that the Red Cross has not seen in 10 years
Top U.S. defense contractors are competing for contracts on hypersonic weapons
Critical Mineral Shortages Could Disrupt Global Supply Chains
Another pandemic may be on the horizon: antimicrobial resistance
European Market for Veterinary Antibiotics
Top predictions for what comes next in 2022
Comparing WordPress Performance on MySQL vs SQLite

Market Research Media

Fintech companies account for roughly 5% of banking revenue in the US and 20% in payments-related fields
CybersecurityMarket.com (Cybersecurity Market): Advanced hackers succeeded in breaking in to Apple’s most guarded fortress
ESGFT.com (ESG Fungible Tokens): Companies are doubling down on ESG
Inflation Bites: The U.S. government can buy fewer infrastructure today
Blockchaining.ai: What is Blockchain Technology and Why is it Popular
MultimodalRetail.com (Multimodal Retail): Should retailers split e-commerce operations from stores?
MetaversePolling.com (Metaverse Polling): What Do Consumers Think of the Metaverse?

Secondary Sidebar

Technologies

Cloudflare R2 Storage directly challenges Amazon S3
Emerging Technologies to Watch in 2022
Cloudflare Unveils New SQL Database Offering
Jupe wants to fix homelessness with affordable and sustainable off-grid housing
Ravn Alaska Orders 30 Hydrogen-Electric Engines from ZeroAvia

Tech Events

Linley Spring Processor Conference 2021, April 22
Extreme Networks “Connect” User Conference Returns to Nashville June 6-9, 2022
Square to Hold Sixth Annual Unboxed Developers Conference on May 12, 2022
SIGGRAPH 2022, 8–11 August 2022, Vancouver
TechCrunch held The Disrupt 2021 online on September 21-23

Footer

Recent Posts

  • Breakthrough VR Basketball App Gym Class Closes $8 Million in Seed Round Led by Andreessen Horowitz
  • Techstars and Audi Launch Pre-Accelerator Program to Promote Innovation in Mobility
  • Latchel Closes $16.7 Million to Enhance Resident Services and Maintenance Workflow
  • Seedtag raises over €250M from Advent International
  • Arable Raises $40 Million to Accelerate Sustainable Agriculture
  • European Quantum Computing Leader IQM Raises €128m Led by World Fund to Help Combat the Climate Crisis
  • Whatnot raises $260M Series D co-led by DST Global and CapitalG to expand its live, social commerce marketplace
  • ZeroAvia Secures Additional $30 Million in Funding from IAG, Barclays, NEOM & AENU
  • Medusa Raises $8m to Build the Leading E-Commerce Platform for Developers
  • Blue Ocean Barns Completes $20 Million Series A Financing, Accelerating Solution to Agricultural Methane Emissions

Dossier

Cloudflare Announces Date of Fourth Quarter 2021 Financial Results
Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
Xait Acquires Privia To Ramp Up In The Government Contracting Market
Elkem commissions two climate-friendly ships for North Sea operation from NCL and MPC Container Ships
When it comes to ESG, we’re just scratching the surface

Press Media Release

Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
The Salvation Army and Convoy of Hope Partner Together to Meet the Needs of Ukrainian Refugees
ADL Says Buffalo Shooter Latest in A Long Line of White Supremacist Terrorists Who Embraced Racist, Antisemitic “Great Replacement Theory”
GlobalConnect keeps growing its customer base and accelerates sustainability efforts in Q2 2022
Apple Expands Today at Apple Creative Studios, Providing New Opportunities to Young Creatives

App Coding

New app to help northeastern Illinois drivers avoid traffic and earn rewards for improving their commute
Digital twins transform the efficiency of current business processes
Distraction-free coding
NLP techniques are bridging the gap between text documents
How to build a search engine

API Coding

Most commonly used HTTP Headers
Neosec Introduces Industry First Expert Managed Threat Hunting Service for Detecting and Investigating API Abuse and Vulnerabilities
RapidAPI opens European headquarters at the new location in Berlin
One AI to Take on Global Language AI Challenge with NLP-as-a-service Platform for Developers
DataGrail Launches API & Agent to Automate DSR Fulfillment Across All Internal Data Systems, Saving Companies Weeks of Engineering Time

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT